國家衛生研究院 NHRI:Item 3990099045/10491
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 913606      線上人數 : 1172
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/10491


    題名: Dipeptidyl peptidase-4 inhibitor LAF-237 improves glucose tolerance and expends graft beta cell mass in diabetic mice transplanted with a sufficient number of islets
    其他題名: Dipeptidyl peptidase-4 inhibitor LAF-237 improves glucose tolerance and expends graft β cell mass in diabetic mice transplanted with a sufficient number of islets
    作者: Juang, JH;Kuo, CH;Chen, CY;Kao, CW;Chen, CT
    貢獻者: Institute of Biotechnology and Pharmaceutical Research
    摘要: Background and aims: Dipeptidyl peptidase-4 (DPP-4) inhibitors increase circulating levels of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide which promote β -cell proliferation and survival. This study tested if DPP-4 inhibition with LAF237 is beneficial for diabetic recipients with a marginal or sufficient number of islets. Materials and methods:We syngeneically transplanted 150 or 300 C57BL/6 mouse islets under the kidney capsule of each inbred streptozotocin-diabetic mouse, and then treated recipients with or without LAF237 (10 mg/kg, po) for 6 weeks. Before and after transplantation, recipients’ blood glucose, body weight and intraperitoneal glucose tolerance test (IPGTT) were measured. At 6 weeks, the grafts were removed to determine insulin content and β-cell mass. Results:In mice transplanted with 150 islets, blood glucose levels decreased in both groups after transplantation, but there were no significant differences between two groups. The area under the curve (AUC) of IPGTT at 2, 4 and 6 weeks were comparable between the LAF237-treated group and controls. Both groups exhibited increased body weights over time, but the differences between two groups were not significant. At 6 weeks after transplantation, the graft insulin content and β-cell mass of grafts were not significantly different between LAF237-treated group and controls. In mice transplanted with 300 islets, blood glucose levels decreased in both groups after islet transplantation, but there were no significant differences between two groups. The AUC of IPGTT at 4 and 6 weeks was lower in the LAF237-treated group than controls (28720 ± 1780 vs. 34840 ± 2136 mg-min, p=0.033 and 26330 ± 1748 vs. 33340 ± 2125 mg-min, p=0.015, respectively). Both groups exhibited increased body weights over time, but the differences between two groups were not significant. At 6 weeks after transplantation, the insulin content of grafts was not significantly different between LAF237-treated group and controls. However, LAF237-treated group had more graft β-cell mass than controls (0.53±0.09 vs. 0.31±0.06 mg, p=0.043). Conclusion:Our results indicate posttransplant LAF237 treatment improves glucose tolerance and expands graft β-cell mass in diabetic recipients transplanted with a sufficient number of islets.
    日期: 2016-08
    關聯: Diabetologia. 2016 Aug;59(Suppl. 1):S198.
    Link to: https://link-springer-com.nthulib-oc.nthu.edu.tw/journal/125/59/1/suppl/page/1
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0012-186X&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000398373701207
    顯示於類別:[陳炯東] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000398373701207.pdf1196KbAdobe PDF341檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋